Harlem Hospital Center

New York, New York 10037

0 studies enrolling now · 19 studies all time

What they study most

COVID-19, Child, Hospitalized, Coronavirus Disease 2019 (COVID-19), Covid19, Early-Stage Breast Cancer, HIV Infection, HIV Infections, Hospitalization, Immunocompromised, Lower Respiratory Tract Disease, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol, Pulmonary Tuberculosis

Studies at this site

• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Immune Modulators for Treating COVID-19 — Completed
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 — Withdrawn before enrolling
• A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) — Stopped early
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection — NO_LONGER_AVAILABLE
• Patient Centered Randomized Controlled Trial — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment — Completed
• TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment — Completed
• Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA — Status unconfirmed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed